Katten Featured in Big Deals Section of American Lawyer in Connection with ImClone - Eli Lilly Merger

Partners Joel A. Yunis and Evan L. Greebel led a Katten team in representing ImClone Systems Incorporated in its $6.5 Billion Sale to Eli Lilly and Company. The firm also represented ImClone in its defense of an unsolicited takeover proposal from Bristol-Myers Squibb Company. Click here to read more about this deal. ("Katten, Latham on $6.5 Billion ImClone-Eli Lilly Deal," October 7, 2008)